Stifel Financial Portfolio holdings
AUM
$103B
This Quarter Return
-0.82%
1 Year Return
+17.55%
3 Year Return
+67.43%
5 Year Return
+118.9%
10 Year Return
+263.91%
AUM
$11.4B
AUM Growth
+$11.4B
(+2.3%)
Cap. Flow
+$466M
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
12.38%
Holding
2,380
New
221
Increased
1,085
Reduced
782
Closed
208
Top Buys
| 1 |
Consolidated Edison
ED
|
$28M |
| 2 |
Deutsche Bank
DB
|
$21.9M |
| 3 |
AbbVie
ABBV
|
$18.7M |
| 4 |
Eli Lilly
LLY
|
$16.9M |
| 5 |
Unilever
UL
|
$16.6M |
Top Sells
| 1 |
Waste Management
WM
|
$31M |
| 2 |
CTRL
Control4 Corporation
CTRL
|
$26.8M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
$25.9M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$20.7M |
| 5 |
Puma Biotechnology
PBYI
|
$13.3M |
Sector Composition
| 1 | Technology | 12.99% |
| 2 | Healthcare | 11.12% |
| 3 | Financials | 9.32% |
| 4 | Industrials | 9.23% |
| 5 | Energy | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares MBS ETF
MBB
$41B
| $55.4M | 0.49% | 512,047 +7,052 | +1% | +$762K |
|
27
McDonald's
MCD
$224B
| $55.2M | 0.48% | 581,951 +158,292 | +37% | +$15M |
|
28
Procter & Gamble
PG
$368B
| $55.1M | 0.48% | 657,902 +6,707 | +1% | +$562K |
|
29
Kimberly-Clark
KMB
$42.8B
| $55M | 0.48% | 511,566 +23,816 | +5% | +$2.56M |
|
30
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $52.7M | 0.46% | 1,263,784 -17,859 | -1% | -$745K |
|
31
ConocoPhillips
COP
$124B
| $52.1M | 0.46% | 680,815 +96,303 | +16% | +$7.37M |
|
32
Boeing
BA
$177B
| $51M | 0.45% | 400,019 +121,440 | +44% | +$15.5M |
|
33
Schlumberger
SLB
$55B
| $49.6M | 0.44% | 488,028 +113,188 | +30% | +$11.5M |
|
34
iShares S&P 500 Value ETF
IVE
$41.2B
| $48.2M | 0.42% | 535,491 -48,397 | -8% | -$4.36M |
|
35
iShares Russell 1000 Growth ETF
IWF
$116B
| $48M | 0.42% | 523,799 +2,559 | +0.5% | +$234K |
|
36
Biogen
BIIB
$19.4B
| $48M | 0.42% | 145,083 -1,685 | -1% | -$557K |
|
37
PepsiCo
PEP
$204B
| $47M | 0.41% | 504,495 -6,772 | -1% | -$630K |
|
38
DuPont de Nemours
DD
$32.2B
| $46.9M | 0.41% | 894,131 -120,395 | -12% | -$6.31M |
|
|
ESRX
39
DELISTED
Express Scripts Holding Company
ESRX
| $45.3M | 0.4% | 641,461 +17,353 | +3% | +$1.23M |
|
40
Visa
V
$683B
| $44.8M | 0.39% | 210,085 -4,826 | -2% | -$1.03M |
|
41
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $43.7M | 0.38% | 360,469 +15,804 | +5% | +$1.92M |
|
|
42
AbbVie
ABBV
$372B
| $43.7M | 0.38% | 756,769 +323,085 | +74% | +$18.7M |
|
43
Vanguard S&P 500 ETF
VOO
$726B
| $43.1M | 0.38% | 238,748 +11,135 | +5% | +$2.01M |
|
44
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.4B
| $42.9M | 0.38% | 499,610 +75,579 | +18% | +$6.48M |
|
|
45
Eli Lilly
LLY
$657B
| $42.7M | 0.38% | 658,959 +260,315 | +65% | +$16.9M |
|
46
Merck
MRK
$210B
| $42.7M | 0.37% | 719,537 +20,867 | +3% | +$1.24M |
|
47
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $42.5M | 0.37% | 503,377 +86,658 | +21% | +$7.32M |
|
48
GSK
GSK
$79.9B
| $42.5M | 0.37% | 924,066 +308,242 | +50% | +$14.2M |
|
49
Mastercard
MA
$538B
| $41.7M | 0.37% | 564,090 +112,410 | +25% | +$8.31M |
|
50
Ionis Pharmaceuticals
IONS
$6.79B
| $41.3M | 0.36% | 1,062,436 +10,208 | +1% | +$396K |
|